Full Description
Newscasts and social networks denounce fraud and professional dishonesty in the healthcare domain quite frequently, even though a few of these are groundless fake news and even scams. This book aims a scientific approach to all forms of fraud, misconduct, and breach of ethics in the healthcare business. Chapters will be written by respected professors worldwide, emphasizing not sensation and impact but a reasoned and scholarly description of the problems, roots, impacts and solutions.
A systematic analysis of each ecosystem and the most prevalent forms of misconduct and unethical procedures will be provided. This encompasses drug manufacturers, health insurance and health maintenance organizations, including telehealth and internet healthcare providers, analytical testing services for clinical services and consumer health purposes, including genomics and other "omics" sequencing, producers and distributors of surgical material, imaging apparatuses and general hospital equipment, personal electronic health monitoring devices, and robotic developers for assistance to small children, the handicapped, the elderly and other medically relevant populations. The emphasis will be descriptive and constructive, about the roots of the issue and involved environments, agents and stakeholders, and concerning what can and should be done to curb the prevalence and consequences of abuses. Medical, scientific, and ethical authorities will be most of the contributors; however, social professionals, lawyers, and economists will help from different vantage points to enrich the messages.
Students, trainees, and professionals are the target, primarily in medicine, pharmacy, nursing, and nutrition, along with business administrators, accountants, and lawyers. All areas of the healthcare business are envisaged, encompassing the related fields of law, social sciences, and the rapidly growing ethics/bioethics field. Policy makers and government agencies should not be overlooked.
Contents
1. Health equity, diversity and inclusion: Critical foundations for ethical leadership.- 2. Should doctors work with the pharmaceutical industry ?.- 3. Industry influence on healthcare provider behaviors.- 4. Promoting world health with equity: From patents to impact funds.- 5. Nursing homes and end of life care: An ethical paradigm ?.- 6. Thick concepts and pharmaceutical industry corruption.- 7. Fake drugs, real concerns.- 8. Ethics of off label marketing of drugs: Patient safety versus commercial profits.- 9. Small pharma ethical behavior.- 10. Informational quarantine: Should it be punishable to spread medical disinformation during a pandemic ?.- 11. Industry payments.- 12. Global implementation of tobacco demand reduction measures specified in framework convention on tobacco control .- 13. Understanding the problems of medical student exposure to pharmaceutical marketing.- 14. Ten challenges to healthcare business ethics in the XXI century.- 15. Ethics and sustainability in food production and consumption. The vegan paradigm .- 16. Bribery in Japan's medical device sector.- 17. Risk of recall among medical devices undergoing US FDA 510(k) clearance and premarket approval.- 18. Implant ethics between business and the clinic.- 19. Xenotransplation.- 20. Internet links to illegal pharmacies.- 21. Illicit online pharmacies.- 22. Dietary supplements adulterated with drugs and contaminated with heavy metals.- 23. Experimental therapies with the application of the EU Hospital Exemption Regulation for Advanced Therapy Medicinal Products - European and Polish perspectives.- 24. Ethics in dental services: business as usual ?.- 25. Advertisement techniques and biologic treatment in psoriasis.- 26. Keeping medical science trustworthy: the threat by predatory journals.- 27. The ethics of internet healthcare crowdfunding.- 28. The complex dynamics of decision-making at the end of life in the intensive care unit.- 29. Medical Board transparency regarding physician sexual misconduct.- 30. Abusive supervision, nursing workforce, and patient safery outcomes.- 31. Dignity in end-of-life care in hospice.- 32. Ethical issues in clinical decision-making about involuntary psychiatric treatment.- 33. Conflicts of interest in biomedical, social and environmental aspects of health.- 34. Ethics of sustainability in healthcare.- 35. Energy conservation and sustainability in the clinical laboratory.- 36. Private equity and its increasing role in the US.- 37. Racism and healthcare in Germany.- 38. Access to healthcare by migrants.- 39. Sexual and reproductive health care for migrant women.- 40. Addressing Socioeconomic Disparities in Healthcare Outcomes of Children in the United States of America.- 41. Ethical Challenges in Mental Healthcare for South Asian, Particularly Sikh, Survivors of Domestic Abuse .- 42. Inclusive Diversity Management in Healthcare: The Ethics of Including the Voices and Experiences of Asian Professionals in Healthcare.- 43. Barriers in healthcare for transgender individuals.- 44. Ethics for artificial intelligence in medicine.- 45. Tribulations and Future Opportunities for Artificial Intelligence in Precision Medicine March 2025.- 46. Business Ethics and the Declaration of Helsinki.- 47. Ethics advancement and internet sites.
